State Expands Vaccination Eligibility

A picture containing person, cellphone, phone

Description automatically generated
Photo Credit: Tyrone Turner / WAMU/DCist

All Fairfax County residents 16 and older can now make COVID-19 vaccination appointments via VaccineFinder.org or call the Fairfax County Health Department at 703-324-7404. The state moved into Phase 2 of vaccine distribution on April 18.

In announcing the new policy, Virginia Gov. Ralph Northam said, “With COVID-19 cases on the rise in many parts of Virginia and across the country, it is important that everyone has an opportunity to make a vaccination appointment. If you are over 16 and want to get the safe, effective, and free vaccine, please make a plan to get your shot.” Northam’s announcement cautions that there may still be delays in finding and booking appointments, given the influx of newly eligible people: “Virginians seeking an opportunity to get vaccinated may have to wait for an appointment, as demand for vaccination is expected to continue to outpace supply in many parts of the Commonwealth.”

People eligible under Virginia’s Phase 1 who are struggling to find an appointment through the VaccineFinder tool will be able to use the old system—vaccinate.virginia.gov or 877-VAX-IN-VA—to register for a priority appointment.

Additionally, the state has also opened a mass vaccination facility in the former Lord & Taylor store at Tysons Corner Mall. This facility will administer up to 3,000 shots a day to county residents. Read more.

Click the link below to access Virginia's COVID-19 web page for updates:

MORE INFORMATION

NOTE: Pfizer-BioNTech has requested that the FDA extend its emergency use authorization of their vaccine to children as young as 12, based on a successful clinical trial that showed the vaccine to be 100% effective among 1,131 vaccinated study participants. Moderna and Johnson & Johnson are also testing their vaccines in this age group. So if you have children 12-15, be alert for an announcement that they can now be vaccinated.


No comments:

Post a Comment